INTERNATIONAL PATENT: CLEARMIND LABS CORP., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. FILES APPLICATION FOR "USE OF 5-METHOXY-2-AMINOINDAN ("MEAI") IN METHODS FOR WEIGHT LOSS AND TREATING FATTY LIVER DISEASE"

GENEVA, Jan. 20 -- CLEARMIND LABS CORP. (101 - 1220 W 6 AveVancouver, British Columbia V6H1A5), YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Edmond Safra Campus, Givat RamP.O. Box 391359139002 Jerusalem) filed a patent application (PCT/IB2025/056865) for "USE OF 5-METHOXY-2-AMINOINDAN ("MEAI") IN METHODS FOR WEIGHT LOSS AND TREATING FATTY LIVER DISEASE" on Jul 08, 2025. With publication no. WO/2026/013547, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZULOFF-SHANI, Adi (c/o CLEARMIND M...